Antimicrobial Agents Practice Questions

Q: All of the following antibiotics can be used to treat cystitis in pregnancy except?

Ciprofloxacin. **Explanation:** The correct answer is **Ciprofloxacin (Option C)**. **Why Ciprofloxacin is contraindicated:** Ciprofloxacin belongs to the **Fluoroquinolone** class of antibiotics. In pregnancy, fluoroquinolones are generally avoided (FDA Category C) because they have a high affinity for bone and cartilage. Animal studies have shown that they can cause **arthropathy** and permanent damage to the weight-bearing joints of the developing fetus (**cartilage toxicity**). Therefore, they are not first-line agents for treating uncomplicated cystitis in pregnant women. **Why the other options are incorrect:** * **Amoxycillin (Option A):** This is a penicillin derivative (FDA Category B). Penicillins are considered safe throughout pregnancy and are commonly used to treat UTIs, although resistance rates are increasing. * **1st Generation Cephalosporins (Option B):** (e.g., Cephalexin) These are FDA Category B drugs. They are highly effective against common urinary pathogens like *E. coli* and are considered safe and first-line for cystitis in pregnancy. * **3rd Generation Cephalosporins (Option D):** (e.g., Cefixime, Ceftriaxone) These are also Category B and are safe alternatives, especially for resistant cases or pyelonephritis. **NEET-PG High-Yield Pearls:** * **Safe Antibiotics in Pregnancy:** "CAMP" — **C**ephalosporins, **A**moxicillin/Ampicillin, **M**acrolides (except Erythromycin estolate), and **P**enicillins. * **Nitrofurantoin:** Safe in the 2nd trimester but avoided in the 1st trimester (risk of birth defects) and at term (risk of neonatal hemolysis/G6PD deficiency). * **Fosfomycin:** A single-dose safe alternative for cystitis in pregnancy. * **Avoid in Pregnancy:** **S**ulfonamides (Kernicterus), **A**minoglycosides (Ototoxicity), **F**luoroquinolones (Cartilage damage), **E**rythromycin estolate (Hepatotoxicity), and **T**etracyclines (Teeth discoloration/Bone hypoplasia) — Mnemonic: **"SAFE T"** (drugs that are NOT safe).

Q: Pyronaridine is:

Antimalarial. **Explanation:** **Pyronaridine** is a potent **benzanaphthyridine derivative** primarily used as an **antimalarial** agent. It was originally developed in China and is structurally related to chloroquine (4-aminoquinoline). **Why it is the correct answer:** Pyronaridine acts by inhibiting the formation of **β-haematin**, preventing the parasite from detoxifying heme into hemozoin. This leads to the accumulation of toxic heme, which destroys the malaria parasite. It is highly effective against both *Plasmodium falciparum* and *Plasmodium vivax*. In modern therapeutics, it is most commonly used in a fixed-dose combination with artesunate, known as **Pyramax®**, which is a WHO-approved **Artemisinin-based Combination Therapy (ACT)**. **Why other options are incorrect:** * **Anti-HIV:** These drugs (e.g., Tenofovir, Efavirenz) target viral enzymes like reverse transcriptase or protease. Pyronaridine has no activity against retroviruses. * **Antifungal:** Antifungals (e.g., Fluconazole, Amphotericin B) target fungal cell membranes or walls. Pyronaridine does not possess antifungal properties. * **Antibacterial:** While some antimalarials (like Doxycycline) have antibacterial properties, Pyronaridine is specific to protozoal parasites. **High-Yield Clinical Pearls for NEET-PG:** 1. **Combination Therapy:** Pyronaridine + Artesunate (Pyramax) is the first ACT to be granted a positive opinion by the EMA for treating both uncomplicated *P. falciparum* and *P. vivax*. 2. **Efficacy:** It is effective against multi-drug resistant strains of *P. falciparum*. 3. **Side Effects:** The most significant concern is a transient rise in **liver transaminases** (ALT/AST); hence, it should be avoided in patients with pre-existing liver disease. 4. **Half-life:** It has a long terminal elimination half-life (approx. 13–17 days), providing a period of post-treatment prophylaxis.

Q: What is the recommended treatment for Entamoeba cyst carriers?

Paromomycin. The treatment of *Entamoeba histolytica* depends on whether the infection is invasive (colitis/liver abscess) or asymptomatic (cyst carrier) [2]. **Why Paromomycin is correct:** Asymptomatic cyst carriers harbor the parasite only within the intestinal lumen. To eradicate these cysts and prevent further transmission, a **luminal amebicide** is required [1]. **Paromomycin** (an aminoglycoside) is poorly absorbed from the GIT, allowing it to reach high concentrations in the gut lumen to kill cysts directly. It is currently considered the drug of choice for asymptomatic cyst passers [1]. **Analysis of Incorrect Options:** * **Metronidazole:** This is a **tissue amebicide** [2]. While it is the drug of choice for invasive intestinal amebiasis and liver abscesses, it is rapidly absorbed from the small intestine and does not reach therapeutic levels in the colon to eradicate luminal cysts [2]. * **Diloxanide furoate:** This was previously the standard luminal amebicide [1]. However, it is no longer available in many countries (including the US) and is generally considered second-line to Paromomycin due to its side effect profile (flatulence). * **Nitazoxanide:** While it has broad-spectrum antiprotozoal activity, it is not the primary recommendation for isolated cyst clearance in *E. histolytica* infections [3]. **High-Yield NEET-PG Pearls:** 1. **Sequential Therapy:** For invasive amebiasis, always follow Metronidazole (tissue amebicide) with Paromomycin (luminal amebicide) to ensure complete eradication of cysts [2]. 2. **Luminal Amebicides:** Paromomycin, Diloxanide furoate, and Iodoquinol [1]. 3. **Tissue Amebicides:** Nitroimidazoles (Metronidazole, Tinidazole), Emetine, and Chloroquine (specifically for liver abscess). 4. **Drug of Choice for Hepatic Amebiasis:** Metronidazole + Diloxanide furoate/Paromomycin.

Q: Which of the following is NOT a beta-lactam antibiotic?

Vancomycin. **Explanation:** The core concept tested here is the structural classification of cell wall synthesis inhibitors. **Beta-lactam antibiotics** are characterized by the presence of a four-membered beta-lactam ring in their molecular structure, which is essential for their antibacterial activity [3]. **Why Vancomycin is the correct answer:** While **Vancomycin** also inhibits bacterial cell wall synthesis, it is a **Glycopeptide** antibiotic, not a beta-lactam [1]. It works by binding to the **D-Ala-D-Ala** terminus of nascent peptidoglycan pentapeptide, sterically hindering the elongation of the peptidoglycan chain [3]. It lacks the beta-lactam ring and therefore does not bind to Penicillin-Binding Proteins (PBPs). **Analysis of incorrect options:** * **Amoxicillin (Option A):** An Aminopenicillin belonging to the **Penicillin** group (classic beta-lactams). * **Aztreonam (Option B):** A **Monobactam**, which is a unique beta-lactam where the ring is not fused to another ring [2]. It is notable for being safe in patients with penicillin allergies (except ceftazidime allergy). * **Ceftriaxone (Option C):** A 3rd-generation **Cephalosporin**, which is a major class of beta-lactam antibiotics [4]. **NEET-PG High-Yield Pearls:** 1. **Mechanism of Beta-lactams:** They inhibit the enzyme **transpeptidase**, preventing the cross-linking of peptidoglycan layers [2], [3]. 2. **Vancomycin Resistance:** Occurs via the replacement of D-Ala-D-Ala with **D-Ala-D-Lac** (seen in VRSA/VRE). 3. **Red Man Syndrome:** A common side effect of Vancomycin due to histamine release (minimized by slow infusion), not to be confused with a true IgE-mediated allergy. 4. **Spectrum:** Aztreonam is active only against **Gram-negative aerobes**, while Vancomycin is active only against **Gram-positive** organisms (including MRSA) [1].

Q: Which antiretroviral therapy (ART) drug is an entry inhibitor?

Enfuvirtide. ### Explanation **Correct Option: A. Enfuvirtide** Enfuvirtide is a fusion inhibitor, a sub-class of **entry inhibitors**. It works by binding to the **gp41** subunit of the viral envelope glycoprotein. This prevents the conformational change required for the fusion of the HIV envelope with the host cell membrane, thereby blocking viral entry. It is unique because it is administered subcutaneously. **Incorrect Options:** * **B. Abacavir:** This is a **Nucleoside Reverse Transcriptase Inhibitor (NRTI)**. It acts by competitively inhibiting the reverse transcriptase enzyme and causing DNA chain termination. (Note: Associated with HLA-B*5701 hypersensitivity). * **C. Efavirenz:** This is a **Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)**. It binds directly to the reverse transcriptase enzyme at a site distinct from the active site, inducing a conformational change that inactivates the enzyme. * **D. Amprenavir:** This is a **Protease Inhibitor (PI)**. It inhibits the viral protease enzyme (HIV-1 protease), preventing the cleavage of polyprotein precursors into mature, infectious virions. **High-Yield Clinical Pearls for NEET-PG:** * **Entry Inhibitors:** There are two main types: 1. **Fusion Inhibitors:** Enfuvirtide (binds gp41). 2. **CCR5 Antagonists:** Maraviroc (binds host CCR5 receptor; requires a "tropism test" before use). * **Attachment Inhibitor:** Fostemsavir (binds gp120) is a newer agent in this category. * **Post-attachment Inhibitor:** Ibalizumab (monoclonal antibody binding CD4). * **Mnemonic for Enfuvirtide:** En**fu**virtide prevents **Fu**sion by binding gp**41** (4+1 = 5, "Fu" sounds like Five).

Q: Which of the following drugs can be used for the prophylaxis of meningococcal meningitis?

Ciprofloxacin. **Explanation:** The goal of prophylaxis in meningococcal meningitis (*Neisseria meningitidis*) is to eradicate the nasopharyngeal carrier state in close contacts of an index case, thereby preventing secondary transmission. **Why Ciprofloxacin is Correct:** **Ciprofloxacin** (a fluoroquinolone) is a preferred agent for adult prophylaxis because a single oral dose (500 mg) effectively eliminates the carrier state. It is highly effective, easy to administer, and reaches sufficient concentrations in respiratory secretions. Other first-line alternatives include **Rifampin** (drug of choice in children, though it requires multiple doses) and **Ceftriaxone** (given as a single IM injection, preferred in pregnancy). **Why Other Options are Incorrect:** * **Chloramphenicol (A):** While it crosses the blood-brain barrier and is used for *treating* bacterial meningitis in patients with severe penicillin allergy, it is not used for prophylaxis due to its potential for serious bone marrow toxicity (aplastic anemia). * **Erythromycin (B):** This macrolide has poor activity against *N. meningitidis* and does not reliably eradicate the nasopharyngeal carrier state. * **Tetracycline (C):** These are bacteriostatic agents that do not achieve the necessary efficacy in the nasopharynx to be recommended for meningococcal prophylaxis. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for Prophylaxis:** Rifampin (600 mg BID for 2 days). * **DOC in Pregnancy:** Ceftriaxone (250 mg IM, single dose). * **Adult Alternative:** Ciprofloxacin (500 mg PO, single dose). * **Note:** Prophylaxis is indicated for "close contacts" (household members, daycare contacts, or healthcare workers exposed to respiratory secretions), not for casual contacts. * **H. influenzae Prophylaxis:** Rifampin is also the drug of choice here, but the dosing schedule differs from meningococcal protocols.

Q: Which of the following drugs is most effective against an organism producing aminoglycoside inactivating enzymes?

Amikacin. The correct answer is **Amikacin**. The primary mechanism of bacterial resistance to aminoglycosides is the production of **aminoglycoside-modifying enzymes (AMEs)**, such as transferases (acetylases, adenylases, and phosphorylases). These enzymes modify the drug molecule, preventing it from binding to the 30S ribosomal subunit. **Amikacin** is a semisynthetic derivative of kanamycin. Its unique chemical structure features a long L-hydroxyaminobutyryl amide (HABA) side chain that sterically hinders the attack of most aminoglycoside-inactivating enzymes [1]. Consequently, Amikacin maintains its potency against many strains that are resistant to other aminoglycosides. It is often reserved for serious nosocomial infections where multi-drug resistance is suspected. **Why other options are incorrect:** * **Streptomycin:** This is the oldest aminoglycoside and is highly susceptible to enzymatic inactivation. It has a narrow spectrum and is primarily used for tuberculosis and plague. * **Gentamicin and Tobramycin:** These are frequently used for Gram-negative infections but are common substrates for AMEs. Bacteria that develop resistance to Gentamicin often show cross-resistance to Tobramycin, as both lack the protective side chain found in Amikacin. **High-Yield NEET-PG Pearls:** * **Spectrum:** Amikacin has the **widest antibacterial spectrum** among aminoglycosides. * **Resistance:** If a Gram-negative organism is resistant to Amikacin, it is typically resistant to all other aminoglycosides. * **Ototoxicity:** While all aminoglycosides are ototoxic, Amikacin is specifically associated with **auditory damage** (cochleotoxicity) more than vestibular damage. * **Rule of Thumb:** Aminoglycosides are "Oxygen-dependent"—they are ineffective against anaerobes because their uptake into the bacteria requires an oxygen-dependent active transport mechanism.

Q: Which one of the following is effective in the treatment of brucellosis?

Rifampicin. **Explanation:** Brucellosis is a zoonotic infection caused by *Brucella* species, which are **facultative intracellular organisms**. Effective treatment requires antibiotics with excellent intracellular penetration and activity in the acidic environment of macrophages. **Why Rifampicin is Correct:** Rifampicin is a bactericidal drug that inhibits bacterial DNA-dependent RNA polymerase. It has **excellent intracellular penetration**, making it a cornerstone in brucellosis management. According to WHO guidelines, the standard treatment for uncomplicated brucellosis is a combination of **Doxycycline (for 6 weeks) plus Rifampicin (for 6 weeks)** or Doxycycline plus Streptomycin. **Why Other Options are Incorrect:** * **Amphotericin B:** This is a polyene antifungal agent used for systemic fungal infections (e.g., Mucormycosis, Leishmaniasis). It has no antibacterial activity. * **Ketoconazole:** This is an imidazole antifungal that inhibits ergosterol synthesis. It is used for superficial fungal infections and Cushing’s syndrome but is ineffective against bacteria. * **Penicillin:** *Brucella* species are inherently resistant to penicillins. Furthermore, penicillins have poor intracellular penetration, making them ineffective against intracellular pathogens like *Brucella*. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Doxycycline + Streptomycin (considered slightly more effective than Doxycycline + Rifampicin in preventing relapse). * **Pregnancy/Children:** Rifampicin + Trimethoprim-Sulfamethoxazole (TMP-SMX) is the preferred regimen, as tetracyclines and aminoglycosides are generally avoided. * **Neurobrucellosis:** Requires a triple regimen (Ceftriaxone + Rifampicin + Doxycycline). * **Diagnostic Test:** Standard Agglutination Test (SAT) is the most common serological test; Rose Bengal Plate Test is used for screening.

Question 1

All of the following antibiotics can be used to treat cystitis in pregnancy except?

Accepted Answer

Ciprofloxacin

Answer

Amoxycillin

Answer

1st generation Cephalosporins

Answer

3rd generation Cephalosporins

Question 2

Pyronaridine is:

Accepted Answer

Antimalarial

Answer

Anti-HIV

Answer

Antifungal

Answer

Antibacterial

Question 3

What is the recommended treatment for Entamoeba cyst carriers?

Accepted Answer

Paromomycin

Answer

Metronidazole

Answer

Diloxanide furoate

Answer

Nitzoxanide

Question 4

A patient with abdominal sepsis was started on empirical treatment with intravenous ampicillin and gentamicin. Which statement regarding the treatment of this patient is most accurate?

Accepted Answer

An antimicrobial agent active against anaerobes should be included in the antibiotic regimen.

Answer

Empirical treatment of abdominal sepsis should always include a third-generation cephalosporin.

Answer

The combination of ampicillin and gentamicin provides good coverage for all likely pathogens.

Answer

If the patient is severely allergic to ampicillin, then ceftriaxone should be used.

Question 5

Which of the following is NOT a beta-lactam antibiotic?

Accepted Answer

Vancomycin

Answer

Amoxicillin

Answer

Aztreonam

Answer

Ceftriaxone

Question 6

Which antiretroviral therapy (ART) drug is an entry inhibitor?

Accepted Answer

Enfuvirtide

Answer

Abacavir

Answer

Efavirenz

Answer

Amprenavir

Question 7

Which of the following drugs can be used for the prophylaxis of meningococcal meningitis?

Accepted Answer

Ciprofloxacin

Answer

Chloramphenicol

Answer

Erythromycin

Answer

Tetracycline

Question 8

Which of the following drugs is most effective against an organism producing aminoglycoside inactivating enzymes?

Accepted Answer

Amikacin

Answer

Streptomycin

Answer

Gentamicin

Answer

Tobramycin

Question 9

Which one of the following is effective in the treatment of brucellosis?

Accepted Answer

Rifampicin

Answer

Amphotericin

Answer

Ketoconazole

Answer

Penicillin

Question 10

A 45-year-old male presents with fever, cough, and anorexia. Sputum is positive for AFB. He is being treated with isoniazid, rifampicin, pyrazinamide, and ethambutol. What is the primary reason for administering multidrug therapy in tuberculosis?

Accepted Answer

To delay the development of drug resistance.

Answer

To broaden the antimicrobial spectrum.

Answer

To prevent toxin release from the organism.

Answer

To reduce drug toxicity.

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?